GLOW targets early tissue response and capillary formation, while BPC-157/TB-500 combo sustains deeper connective tissue remodeling
BPC-157s effects on multiple neurotransmitter systems create theoretical interaction points with psychiatric medications, yet interactions are not well studied. Particular concerns include serotonin syndrome risk when combined with SSRIs (since BPC-157 modulates serotonin in complex regional patterns), unpredictable effects on dopaminergic medications (antipsychotics, ADHD treatments, Parkinsons medications), and unknown interactions with benzodiazepines despite the animal studies showing tolerance prevention
Once the procedure is completed, any remaining gel or markings are removed, and youre free to go on with your day there is no downtime required with EXILIS
There are also questions about semaglutide and fatigue , dizziness , and other systemic effects that users should understand before starting
3-6+ Months: With consistent, proper application, the more profound effects can be observed
As with any treatment that involves an IM there is a risk for infection
